61
Views
9
CrossRef citations to date
0
Altmetric
Research Article

Epicutaneous Exposure to Anticoagulant Rodenticide Warfarin Modulates Local Skin Activity in Rats

, , &
Pages 1-13 | Published online: 10 Oct 2008

REFERENCES

  • Sullivan JB, Levine JR, Bangert JL, Maibach H, Hewitt P. Clinical dermatotoxicology. In: Sullivan JB, Krieger GR, eds. Clinical Environmental Health and Toxic Exposures., PA: Lippincot, Williams & Wilkins; 2001:182–206.
  • Spiewak R. Pesticides as a cause of occupational skin disease in farmers. Ann Agric Environ Med 2001; 8: 1–5.
  • Shearer MJ. Vitamin K and vitamin K-dependent proteins. Br J Haematol 1990; 75: 156–162.
  • Lund M. (1988) Anticoagulant rodenticides. In: Prakash I, ed. Rodent Pest Management. Boca Raton, FL: CRC Press; 1988:341–351.
  • Price PA. Role of vitamin K-dependent proteins in bone metabolism. Anu Rev Nutr 1988; 8: 565–583.
  • Nakano T, Kawamoto K, Kishino J, Nomura K, Higashino K, Arita H. Requirement of gamma-carboxyglutamic acid residues for the biological activity of Gas6: contribution of endogenous Gas6 to the proliferation of vascular smooth cells. Biochem J 1997; 323: 387–392.
  • Yanagita M, Ishii K, Ozaki H, Arai H, Nakano T, Ohashi K, Mizuno K, Kita T, Doi T. Mechanism of inhibitory effect of warfarin on mesangial cell proliferation. J Am Soc Nephrol 1999; 10: 2503–2509.
  • Kater AP, Peppelenbosch MP, Brandjes DPM, Lumbantobing M. Dichotomal effect of the coumadin derivative warfarin on inflammatory signal transduction. Clin Diag Lab Immunol 2002; 9: 1396–1397.
  • Varnum B, Young C, Elliot G, Garcia A, Bartley TD, Fridell YW, Hunt RW, Trail G, Clogston C, Toso RJ, Yanagihara D, Bennett L, Sylber-Tseng E, Escobar E, Liu ET, Yamane HK. Axl receptor tyrosine kinase stimulated by the vitamin K-dependent protein encoded by growth-arrest specific gene 6. Nature 1995; 373: 623–626.
  • Avanzi GC, Gallicchio M, Bottarel F, Gammaitoni L, Cavalloni G, Buonfiglio D, Bragardo M, Bellomo G, Albano E, Fantozzi R, Garbarino G, Varnum B, Aglietta M, Saglio G, Dianzani U, Dianzani C. Gas6 inhibits granulocyte adhesion to endothelial cells. Blood 1998; 91: 2334–2340.
  • Kataranovski M, Vlaški M, Kataranovski D, Tošić N, Mandić-Radić S, Todorović V. Immunotoxicity of epicutaneously applied anticoagulant rodenticide warfarin: evaluation by contact hypersensitivity to DNCB in rats. Toxicology 2003; 18: 83–100.
  • World Health Organisation. Anticoagulant Rodenticides. WHO Environmental Health Criteria, No 175, Geneva; 1995:1–121.
  • Friested B, Sterner N. Warfarin intoxication from percutaneous absorption. Arch Environ Health 1965; 11: 205–208.
  • DiPalma JR. Human toxicity form rat poisons. Am Fam Physician 1981; 24: 186–189.
  • Abell TL, Merigian KS, Lee JM, Holbert JM, McCall JW. Cutaneous exposure to warfarin-like anticoagulant causing an intracerebral hemorrhage: a case report. Clin Toxicol 1994; 32: 69–73.
  • Farrar A, Cabral R. Recent epidemics of poisoning by pesticides. Toxicol Lett 1995; 82/83:55–63.
  • Spiller HA, Gallenstein GL, Murphy MJ. Dermal absorption of a liquid diphacinone rodenticide causing coagulopathy. Vet Hum Toxicol 2003; 45: 313–314.
  • Martin-Boyer G, Khanh NB, Linh PH. Epidemic of hemorrhagic disease in Vietnamese infants caused by warfarin-containing talc. Lancet 1983; 1: 230–232.
  • Huckle KR, Morrison BJ, Warburton PA. The percutaneous fate of the rodenticide flocoumafen in the rat: role of non-biliary intestinal excretion. Xenobiotica 1989; 19: 63–74.
  • Beckley-Kartey SA, Hotchkiss SA, Capel M. Comparative in vitro skin absorption and metabolism of coumarin (1,2-benzopyrone) in human, rat and mouse skin. Toxicol Appl Pharmacol 1997; 145: 34–42.
  • Kataranovski M, Prokic V, Kataranovski D, Zolotarevski L, Majstorovic I. Dermatotoxicity of epicutanepously applied anticoagulant warfarin. Toxicology 2005; 212: 206–218.
  • Kataranovski M, Stošić-Grujučić S, Lukić M. Dissection of stimulatory and inhibitory effects of epidermal cells on T cell proliferation. Iugoslav. Physiol. Pharmacol. Acta 1988; 24: 547–548.
  • Popov VI, Rogacevski VV, Gapeev AB, Khramov RN, Fesenko EE. Degranulation of skin mast cells caused by high frequency electromagnetic irradiation of low intensity. Biofizika 2001; 46: 1096–1102.
  • Johanson O, Gangi S, Liang Y, Yoshimura K, Jing C, Liu PY. Cutaneous mast cells are altered in normal healthy volunteers sitting in front of ordinary TVs/PCs: results from open-field provocation experiments. J Cutan Pathol 2001; 28: 513–519.
  • Wang HW, Nicodemus T, Andrew RL, Wakefield D, McNeil PH. Mast cell activation and migration to lymph nodes during induction of an immune response in mice. J Clin Invest 1998; 102: 1617–1626.
  • Al-Humadi NH, Shvedova AA, Batteli L, Diotte N, Castranova V, Kommineni C. Dermal and systemic toxicity after application of semisynthetic metal-working fluids in B6C3F1 mice. J Toxicol Environ Health 2000; 61: 579–589.
  • Galli SJ, Maurer M, Lantz CS. Mast cells as sentinels innate immunity. Curr Opin Immunol 1999; 11: 53–59.
  • Shvedova AA, Kisin E, Murray A, Smith C, Castranova V, Kommineni S. Enhanced oxidative stress in the skin of vitamin E deficient mice exposed to semisynthetic metal working fluids. Toxicology 2002; 176: 135–143.
  • Santos FX, Arroyo C, Garcia I, Blasco R, Obispo JM, Hamann C, Espejo L. (2000) Role of mast cells in the pathogenesis of postburn inflammatory response: reactive oxygen species as mast cell stimulators. Burns 2000; 26: 145–147.
  • Trautmann A, Feuerstein B, Ernst N, Brocker EB, Klein CE. Heterotypic cell-cell adhesion of human mast cells to fibroblasts. Arch Dermatol Res 1997; 289: 194–203.
  • Nishikori Y, Kakizoe E, Kobayashi Y, Shimoura K, Okunishi H, Dekio S. Skin mast cell promotion of matrix remodeling in burn wound healing in mice: relevance of chymase. Arch Dermatol Res 1998; 290: 553–560.
  • Noli C, Miolo A. The mast cell in wound healing. Vet Dermatol 2001; 12: 303–313.
  • Levi-Schaffer FL. Mast cell/fibroblast interactions in health and disease. Chem Immunol 1995; 61: 161–185.
  • Eady RAJ, Cowen T, Marshall TF, Plummer V, Greaves MW. Mast cell population density, blood vessel density and histamine content in normal skin. Br J Dermatol 1979; 100: 635–640.
  • Norrby K. Mast cells and angiogenesis. APMIS 2002; 110: 355–371.
  • Williams IR, Kuper TS. Immunity at the surface: homeostatic mechanisms of the skin immune system. Life Sci 1996; 58: 1485–1507.
  • Haussiau F, vanSnick JV. IL-6 and T cell response. Res Imunol 1992; 143: 740–743.
  • Kataranovski M, Karadaglić DJ. Skin organ culture: A review. Acta Dermatovenerol 1999; 8: 131–140.
  • Tanaka T, Kawabata K, Kakumoto M, Makita H, Hara A, Mori H, Satoh K, Murakami A, Kuki W. Citrus auraptene inhibits chemically induced colonic aberrant crypt foci in F344 rats. Carcinogenesis 1997; 18: 2155–2161.
  • Hermes B, Haas N, Henz BM. Immunopathological events of adverse cutaneous reactions to coumarin and heparin. Acta Derm Venereol 1997; 77: 35–40.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.